Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer (Q39137546)

9 September 2017

title

Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer (English)

1 reference

9 September 2017

1 reference

1 reference

1 reference

Hung-Chih Hsu

1

1 reference

9 September 2017

Yi-Shiuan Liu

2

1 reference

9 September 2017

Kai-Chi Tseng

3

1 reference

9 September 2017

Cheng-Lung Hsu

4

1 reference

9 September 2017

Ying Liang

5

1 reference

9 September 2017

Tsai-Sheng Yang

6

1 reference

9 September 2017

Jinn-Shiun Chen

7

1 reference

9 September 2017

Rei-Ping Tang

8

1 reference

9 September 2017

Shu-Jen Chen

9

1 reference

9 September 2017

Hua-Chien Chen

10

1 reference

9 September 2017

publication date

20 June 2013

1 reference

International Journal of Colorectal Disease

9 September 2017

published in

1 reference

9 September 2017

volume

28

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

1535-1546

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

9 September 2017

1 reference

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Intra-tumour heterogeneity: a looking glass for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Cancer stem cells: current status and evolving complexities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Stem cells and their implications for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Colon cancer stem cells: implications for prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Identification of stem cells in small intestine and colon by marker gene Lgr5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Crypt stem cells as the cells-of-origin of intestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Common cancer stem cell gene variants predict colon cancer recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-013-1721-X

Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma

21 January 2018

1 reference

12 December 2020

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

12 December 2020

Cancer stem cells: an evolving concept

1 reference

12 December 2020

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

12 December 2020

1 reference

12 December 2020

Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer

1 reference

12 December 2020

Significance of Lgr5(+ve) cancer stem cells in the colon and rectum

1 reference

12 December 2020

Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study

1 reference

12 December 2020

10.1007/S00384-013-1721-X

Identifiers

DOI

1 reference

9 September 2017

1 reference